David Loucks is Chairman and Chief Executive of Healthios. Throughout his career, Mr. Loucks has been an advisor, financier, and general manager throughout the healthcare industry, in the process nurturing an experienced perspective on capital markets, development cycles and value creation.
Prior to founding Healthios, Mr. Loucks, was the founder and Managing Partner of the Aethena Group, LLC., a private equity partnership with a broad portfolio of investment interests. From 1998 until 2001, Mr. Loucks served as President and CEO of Physician Dynamics, Inc. ("PDI"), a fully-integrated provider of technology-enabled care management solutions for patients afflicted with chronic and acute diseases. Services comprising patient & family education, compliance management, utilization review, outcomes measurement, informed consent, mobile health, and remote monitoring were sold to hospitals, health plans, and providers throughout the U.S. In September 2000, PDI was sold to Landacor, a publicly-traded healthcare information technology company.
Prior to Physician Dynamics, from 1994 through 1998, Mr. Loucks was a Vice President with Robertson, Stephens & Company, a global investment banking firm. Among his duties at Robertson Stephens, Mr. Loucks was a founder of the Special Situations practice and he directed that firm's first international financing initiatives for companies based in Europe, Israel, India, and China.
Mr. Loucks holds a BA from Yale University and an MBA from Northwestern. As a rower, Mr. Loucks is a former National Champion.
David B. Loucks
Christoph Brandenberger is a Managing Director at Healthios Capital Markets, focusing on a wide range of M&A, financing and strategic advisory mandates in medical devices. At Healthios Mr. Brandenberger has lead deal teams that have advised a diverse group of clients on M&A, cross-border M&A, strategic partnering and financing assignments.
Prior to joining Healthios in 2010, Mr. Brandenberger worked in various operating roles and ultimately as General Manager for an European multinational company. Mr. Brandenberger started his career in Corporate Finance and M&A at Montgomery Securities in Boston. He holds a MBA from the University of Vienna, Austria.
Mr. Culiuc is a Managing Director at Healthios, focusing on a wide range of M&A, financing and strategic advisory mandates in healthcare technology and services. His transaction experience includes work on more than 50 M&A and financing transactions totaling over $10 billion in value.
Prior to joining Healthios in 2008, Mr. Culiuc was an associate at Credit Suisse investment banking group in New York and Chicago where he worked on a variety of M&A and strategic advisory as well debt and equity raise transactions spanning industrial, media and services sectors.
Besides investment banking, Mr. Culiuc work experience includes stints at the International Monetary Fund in Washington D.C., and Ministry for Foreign Affairs of Moldova (Embassies in Austria and Germany). Mr. Culiuc holds an MBA from the Graduate School of Business at University of Chicago. He is multi-lingual and has spent over 20 years overseas in his professional roles.
Mr. Shearer is a Managing Director at Healthios, focusing on a wide range of M&A, financing and strategic advisory mandates in the orthopedics, respiratory, anesthesiology and ophthalmology device sector and the healthcare services sector. He served as a Managing Director or Vice President at Kidder Peabody (1983-1988), Banker's Trust (1988-1991), Vector Securities International, Inc, (1992-1996) and Jefferies & Co. (1996-1998). At these firms, Mr. Shearer provided leadership in over 150 transactions which included Mergers and Acquisitions, private offerings of equity and debt and public offerings of equity and debt. Greg has a BA from Centre College and an MBA in Finance and Accounting from the University of Chicago.
Jasmi Shah is a Vice President at Healthios.
Prior to Healthios, Ms. Shah was an Accelerator for Sterling Partners, working as part of the executive team for one of their portfolio companies.
Ms. Shah has also held positions at The Carlyle Group, Shore Capital Partners, The MasterCard Foundation and in the Corporate Strategy Group at Deloitte. She began her career as an Analyst in the Investment Banking Group at Credit Suisse.
Ms. Shah received her BBA (with honors) from the Schulich School of Business, York University and MBA (dean's list) from the Kellogg School of Management, Northwestern University.
Michael Justin Martinez is an Analyst at Healthios.
Prior to Healthios, Mr. Martinez was at the Yale Group, a boutique investment banking firm based in Denver, Colorado. He was involved in M&A, partnering, and financing transactions. Prior to the Yale Group, Mr. Martinez was an Associate at Morgan Stanley Wealth Management, working with clients to implement financial planning and optimize portfolio allocations.
Mr. Martinez holds a BSc in Biomedical Engineering from the Johns Hopkins University with a concentration in cell and tissue engineering. In addition, his primary research involved dynamic modeling of a wide variety of pharmaceutical mechanisms.
Michael Justin Martinez
Brian D. Gibson is Controller and is responsible for the firm's accounting. Prior to joining Healthios, Mr. Gibson was Assistant Controller at Vestor Capital LLC, a dually registered Broker/Dealer and Registered Investment Advisor, which provides comprehensive wealth management services to high net worth individuals and families. Prior to Vestor, Mr. Gibson held positions as a Credit Analyst for an alternative asset manager, Denali Capital LLC, and began his career with KPMG, LLP in the Chicago Audit Practice. He is a CPA and has a BBA in Accountancy and MS in Accountancy from the University of Notre Dame.
Laura McKevitt is Director of Business Applications responsible for providing the strategic leadership, vision and consultation to achieve strategic goals and deliver best-in-class technology solutions across the organization.
Prior to joining Healthios, Ms. McKevitt worked as a Business & Technology Consultant helping a wide range of clients solve complex business problems through applied technologies - from small businesses to Fortune 500 companies. Prior to consulting, she worked as a CRM and Program Manager for an international billion dollar publicly held corporation and 2008 Inc. 500 fastest growing private software companies in the U.S. Early in her career she was the General Manager for a million dollar mobile electronics retail department.
Throughout her career, Ms. McKevitt has worked as a trusted advisor and expert technical resource alongside IT and other strategic business segments to listen, align and drive the highest quality experiences for customers and stakeholders. With a deep understanding of customer relationship management, marketing strategies, systems integration and analytics, she has successfully led onshore and offshore project teams through complex deployments.
Ms. McKevitt graduated from DePaul University with a Bachelors of Arts, Entrepreneurship concentration. She maintains 3 Salesforce.com Professional Certifications as a Systems Administrator, Implementation Expert and Developer. She is also a member of the American Marketing Association, Chicago Chapter.
Laura J. McKevitt
Jane Phornprapha is a Vice President at Healthios.
Before joining Healthios, Ms. Phornprapha was a financial analyst at P. Thailand Machinery Co., Ltd., a holding company investing in automobile business, a company based in Bangkok, Thailand. Prior to P. Thailand Machinery, she served as a credit analyst at UOB (Thailand), the subsidiary of United Overseas Bank, the number one bank in Singapore. Ms. Phornprapha graduated from Chulalongkorn University, Thailand in 2002. In 2006, she earned her Master of Business Administration, majoring in finance, from University of Notre Dame.
Thanakorn Chinpeerasatian is a recent MSc graduate from Cass Business School, and hold a BSc from Newcastle University.
Prior to joining Healthios, Mr. Chinpeerasatian was an intern at Transaction Advisory (TAS) department EY (Thailand), where he learnt to identify appropriate comparable companies to compare with target firms and carried out research to highlight the pros and cons of corresponding M&A deals. Internship at Thanachart Securities PCL allowed Mr. Chinpeerasatian to be part of a broker team, where he was given opportunities to work on asset allocation strategies for different types of customers to meet their financial needs and risk return profile.
Puthinun Kaojarern is an investment banking analyst at Healthios.
Prior to joining Healthios, Mr. Kaojarern was an investment banking analyst at Phatra Securities, a leading investment bank in Thailand, where he was responsible for various deals, including M&A transactions and corporate restructuring. Prior to Phatra Securities, Mr. Kaojarern worked as a senior finance officer at Fragrant Property, a real estate developer, where he was responsible for financial management and analysis of the company and its subsidiaries.
Mr. Kaojarern graduated from Chulalongkorn University in 2012 with a Bachelor’s degree in Economics. In 2015, he passed the CFA level II.
Kasama Limpanukorn has been an Analyst at Healthios since November of 2014.
At Healthios, Mr. Kasama has been involved in a variety of M&A, partnering, and financing transactions. He has experience with all aspects of the deal process including leading the due diligence phase. He has analyzed market trends, positioning, and developed both financial and valuation models. Prior to joining Healthios, Kasama was an intern at Bangkok Bank, the largest commercial bank in Thailand and Phatra Securities, a leading securities company specialized in investment banking.
Kasama graduated from Chulalongkorn University in 2014 with a Bachelor’s degree in Finance. While in university, he received many awards in financial competitions including the national champion trophy in Thailand CFA Institute Research Challenge.
Before joining Healthios, Mr. Mazenc was President of the Global Business Forum, a non-profit organization/think tank based in Canada, focused on solving economic and financial issues across the globe. The organization enabled startups to reach their full potential by organizing events which allowed them to showcase themselves to venture capital firms. Prior to GBF, he served as an equity research analyst at Probus, a Swiss-based Asset Management firm. He provided equity research and analysis for emerging markets fund focused on Southeast Asia.
Multi-lingual with experience in Asia, Europe, and North America, he is familiar with the cross-border team work environment. In 2016, Mr. Mazenc graduated with a Bachelor of Business Administration from HEC Montreal and successfully passed the CFA Level 1.
Tongpol Praphonphan has been an Analyst at Healthios since March, 2015.
Prior to Healthios, Mr. Praphonphan was an intern at the Bank of Thailand in the Macroeconomic and Monetary Policy Department, where he was responsible for developing a Stock Market Monitoring Model to detect stock market prices instability.
Mr. Praphonphan holds an MSc from University College London and a BSc from Queen Mary University of London (Hons).
Suwiporn Chailaisathaporn, also known as Kukkik, started working with Healthios as an Executive Assistant in May, 2016.
Before joining Healthios, Ms. Suwiporn was an English Translator & Overseas Co-ordinator at a gaming company called Winner Online based in Bangkok. Prior to Winner Online, she worked as a Young Leaner Assistant at British Council Thailand (Satit Chula Prathom).
Ms. Suwiporn graduated from the University of the Thai Chamber of Commerce with a First Class Honours degree in English and Translation. She is currently studying for her Master’s in Applied Psychology (Counselling) at Srinakharinwirot University.
Peat Wanichakul is a Senior Technical Business Analyst responsible for gathering business requirements, documenting business processes and collaborating with the technology development team to deliver best-in-class technology solutions across the organization.
Mr. Wanichakul joined Healthios Capital Markets as an Investment Banking Analyst in 2014 before joining the technology team in 2015. Prior to Healthios, Mr. Wanichakul worked as a Financial Software Engineer at Thomson Reuters developing financial applications for Thomson Reuters’ Eikon product.
Mr. Wanichakul holds a BSc (Hons) in Computer Science from University of St Andrews and an MSc in Strategic Management from Cass Business School.
Dr. Steven Fang founded CordLife Singapore in 2001, and merged his company with Cytomatrix USA in 2003. The merged companies were renamed CyGenics Ltd which successfully Listed 18th June 2004 on the Australian Stock Exchange. CyGenics was subsequently renamed CordLife in 2007 to focus on its core business of Human Umbilical Cord Blood Banking. It continues its technology development through Cytomatrix in strategic partnership with Australia’s Deakin University. In March 2012, Cordlife Ltd spun out its matured businesses into Cordlife Group (CGL) Ltd which subsequently listed on SGX.
Steven has over 25 years of Market and Corporate Development experiences in the healthcare, medical device and biotechnology industry. Past management track record includes such global MNCs as Sterling Winthrop (GSK – LSE/NYSE), Baxter Inc (BAX – NYSE) and Becton Dickinson (BDX – NYSE). During his tenure, Steven helmed various functional and managerial positions in United States, Singapore, Malaysia, Korea, Taiwan, and the Philippines. Steven was the General Manager for South East Asia at Becton Dickinson before starting Cordlife.
Steven currently serves on the Singapore British Business Council, Advisory Board for Ngee Ann Polytechnic Life Science (LSAC), Pro-Enterprise Panel (PEP) with the Singapore Ministry of Trade, Deputy Chairman with SPRING’s Action Community for Entrepreneurship (ACE) and currently serves on the Ministry of Education – ASPIRE R3 Committee. He was previously the Chairman of Bio Singapore and served as Chairman / President of Spirit of Enterprise (SOE). Steven incubated 6 other technology startups as founder or as an Angle Investor and coach. He is also a Member of the Singapore Institute of Director.
Steven has received the following awards:
- Spirit of Enterprise Award, 2005
- World Economic Forum (Davos) Technology Pioneer Award, 2007
- Ernst & Young Entrepreneur of the Year Award, Technology Innovation, 2007,
- Asia Pacific Entrepreneurship Awards, 2010
- Spirit of Enterprise Honorary Award, 2011
Steven holds his first degree in Computer Science, an MBA in Corporate Strategy with the University of Hull (UK), eMBA INSEAD, eMBA Tsinghua Univeristy (Beijing), Advanced Management Program with NTU / Berkeley (USA) and a PhD in Biotechnology and Strategic Management with the University of South Australia.
Mr Chen is the Managing Partner for Clearbridge Partners, an Asian venture capital firm. He is also the Managing Partner for Clearbridge Accelerator, a Singapore National Research Foundation (NRF) backed high-technology incubator and Chairman for the management committee of Clearbridge BSA Pte Ltd.
Prior to founding Clearbridge Accelerator, Mr Chen worked at Pacific Century CyberWorks Limited (PCCW), the incumbent and leading telecommunications company in Hong Kong. Mr Chen is a member of the pioneering team at PCCW and was the President of CyberWorks Ventures, the Venture Capital and direct investment arm of PCCW. Mr Chen was also the youngest member of PCCW's Mergers & Acquisitions executive committee, and was responsible for much of PCCW's strategic expansion and many of its successful acquisitions and investments.
Mr Chen has more than 18 years of entrepreneurship experience with start-ups, being the co-founder of 2 start-up companies with successful exits. Mr Chen has also given talks on entrepreneurship in Hong Kong, Singapore and the United States. Mr Chen is an active angel investor and was a member of the Hong Kong Science and Technology Park (HKSTP) incubator selection panel and a venture committee member of the Hong Kong Venture Capital and Private Equity Association (HKVCA). He is also currently a member of the Singapore NRF POC grant panel and a member of NTUitive SRIF committee.
Mr Chen is the recipient of the prestigious Sword of Honour from the Singapore Armed Forces, and holds a B.A., M.A. and M.Eng from the University of Cambridge, U.K..
Mr Mohamed Nasser is Senior Vice President and Head of SME Development and Listings at SGX. Prior to assuming his present responsibilities in 2014, Mr Nasser headed the Issuer Regulation Unit in SGX. In that role, Mr Nasser was responsible for overseeing the review of listing applications by issuers and the monitoring of listed companies’ compliance with the listing rules. His duties include regular liaison with regulators and representing SGX’s interests in the development and implementation of regulatory initiatives. Mr Nasser had also led in various regulatory roles within SGX including Enforcement, Regulatory Policy as well as Legal and Compliance.
Prior to joining SGX in 2005, Mr Nasser was a State Counsel with the Attorney General’s Chambers. In his current role, Mr Nasser is responsible for marketing and developing SGX’s Catalist for fast growing companies. His responsibilities include the development of initiatives to provide greater fund-raising services for companies, including the development of Capbridge, a capital raising platform for high-growth companies. Mr Nasser also spearheads various initiatives to encourage the listing of digital companies on SGX.
Mohammed Nasser Ismail
Yong Chye is a Portfolio Manager with the Equities Department of GIC. He has held a number of roles in the organisation to date, previously serving as an Economist covering Japan, a portfolio manager with the European equities group, followed by a stint as a Global Macro portfolio manager. He is currently managing a Global Emerging Equities portfolio in GIC.
Prior to his employment, Yong Chye received the GIC Overseas Scholarship for studies at Osaka University, graduating with a BA in Economics. He has also completed the MSc. in Wealth Management Program at the Singapore Management University, and is a CFA Charterholder.
Frederick Reichenbach has been a Managing Member of Healthios Capital Markets LLC (HCM) since the firm’s founding in January 2012. HCM is a boutique investment bank serving the global healthcare industry. HCM works to structure transactions that fulfil the goals of all participants in a given sector; investors, emerging growth companies, and large cap strategic companies. Mr. Reichenbach’ s clients have included entities in the US, India, UK, Ireland, The Netherlands, Germany and Singapore.
Transactions completed include M&A, strategic partnering and capital raising for these companies. Under his leadership Healthios entities have advised on 40 corporate finance transactions with a value of over $1.4 billion, largely for the portfolio companies of venture capital firms. In addition to actively advising clients, Mr. Reichenbach is also deeply involved in the management of the firm. He is qualified as a principal of the firm under FINRA regulations and supervises the activities of other investment bankers. Mr. Reichenbach also oversees administrative functions of the firm including compliance, accounting, and human resources.
Prior to leading HCM Mr. Reichenbach was a Managing Director of Healthios, Inc. (“Healthios”), a healthcare consulting and advisory firm, since the firm’s founding in 2005. His client industry focus has been on biologics, medical device, medical products, and disease management with an emphasis on supporting executives and/or private equity firms in aligning their operating plan and leadership with a strategic direction.
Prior to his role at Healthios, from 2002 through 2005, Mr. Reichenbach was associated with the Aethena Group, LLC. (“Aethena”) as a Vice President. Aethena was a consulting and strategic advisory firm also focusing on the healthcare sector. As an executive at Aethena Mr. Reichenbach led advisory mandates for private equity firms in deals worth $5.3 billion in enterprise value, $3.0 billion of which were final binding bids in auctions.
Prior to joining Aethena, Mr. Reichenbach served as Chief Financial Officer for the Advanced Group of Companies, a healthcare-staffing firm, and InLight, Inc., a patient education and disease management company. Experiences included completing installing PeopleSoft HR and Finance, two capital financings amounting to $15 million and five M&A transactions representing aggregate transaction value in excess of $120 million.
Previous to his CFO roles Mr. Reichenbach was a Partner (among 8) in the London office of the Central Europe Trust (CET), a prominent advisory firm specializing in Central and Eastern Europe. CET operated under the Chairmanship of Nigel Lawson, Exchequer under Prime Minister Thatcher. During Mr. Reichenbach’s tenure the firm generated $120M in revenue, closed 50 significant M&A transactions, and raised and managed $400M in private equity.
Mr. Reichenbach started his career at Accenture (formerly Andersen Consulting). He graduated from Yale University with a Bachelor of Arts in Economics and received a Masters of Management from the Kellogg Graduate School of Management at Northwestern University in 1992.
Nick Caldwell is a Managing Director of CapBridge, which is based in the global financial centre of Singapore. Capbridge is a Private Institutional Market that supports growth companies to transact globally. Deal types include venture financing, security placement, and pre-IPO placements.
He is a Chartered Accountant with over 25 years of experience in Venture Capital, Private Equity, Corporate Finance, M&A, and investing in private companies and public markets.
Nick began his career in UK and moved to South East Asia in 1997 with KPMG Jakarta and then KPMG Singapore from 2001 to 2004. During this time, he held lead advisory roles in global, regional and domestic M&A transactions, advising on over 50 deals. His sector experience includes: Automotive, Chemicals, Defence, Electronics, Healthcare & Pharmaceutical, Insurance, Leasing, Manufacturing, Resources, Property, Technology and Telecommunications.
In 2004, Nick became an entrepreneur where he co-founded and built an online retail mutual funds platform, which was later sold to an international wealth manager in July 2008. Subsequently, he founded a Singapore-based boutique corporate finance advisory firm, advising Emerging Growth companies in Venture Capital, Private Equity, pre-IPO, IPO listings, private placements, and debt arrangements. After which, he went on to invest the public and private markets for a privately owned hedge fund, where he originated, structured, and managed a listed equity portfolio and also invested in Venture Capital, Private Equity, pre-IPO, IPO, and RTO listings in Singapore, Australia, and Canada.
Nick graduated from the University of Dundee, Scotland and holds a Bachelor of Accountancy degree with honours. He was admitted as a Chartered Accountant by the Institute of Chartered Accountants of Scotland in 1996.
Alvin joined CapBridge in August 2016. He is an experienced senior investment banker with more than 18 years of extensive professional experiences in cross border M&A, IPO, private equity, private placement, pre-IPO fund raising, etc. across the region.
Before joining CapBridge, Alvin was with the top investment bank in China – China International Capital Corporation (“CICC”) based in Beijing/Hong Kong/Singapore from April 2007 to July 2016, Credit Suisse Hong Kong from 2005 to March 2007, Ernst & Young Hong Kong from 2001 to 2005 and Arthur Andersen Malaysia 1998 to 2000.
Alvin has successfully completed in some of the high profile cross-border IPO and M&A transactions, which include but not limited to: Kazakhmys dual listing in HKEx (market cap of USD 15 billion during the transaction period); Freetech Technology’s Hong Kong IPO (market cap of USD 400 million during the transaction period); China Oilfield Services Limited’s 100% acquisition of Norwegian listed company Awilco (USD 2.5 billion); China Investment Corporation ("CIC")’s investment in Indonesian Bumi Resources (USD 1.9 billion); CIC’s investment in a Mongolian Iron Ore Company (USD 700 million); Guangdong Rising Asset Management’s USD 200 million investment in Australian listed company PanAust (with assets based in Laos, Myanmar and Thailand); Lenovo’s 100% acquisition of Brazil based CCE (USD 200 million); China Mobile acquisition of 18% True Corp in Thailand (USD 881 million); JCET-SC’s privatisation of SGX listed STATS ChipPAC (USD 780 million), etc.
Alvin graduated from University of Cambridge, United Kingdom with a MPhil in Finance and awarded with a First Class Honours in B.A. (Hons) Accounting & Financial Management from University of Essex, United Kingdom. He is a Scholar of Cambridge Commonwealth Trust, as well as British Council British Scholarship.
Mr. Choo is the SVP (Investments & Operations) of CapBridge. His responsibilities range from managing the strategic partnerships of the CapBridge, implementation of all online/offline workflows of the platform, and executing the marketing strategy to onboard both Investors and companies.
Prior to CapBridge, Mr. Choo was Senior Investment Director at Clearbridge Accelerator, a strategic partner of CapBridge, where his responsibilities include VC deal sourcing, portfolio companies support and portfolio management. He previously worked in the Technology transfer department of the NUS Industry Liaison Office where he focused on innovation relating to Advance Materials. He started his career as an investment banking analyst at ReEx Capital Asia, where he specialized in the Asian Clean Energy sector.
Haiping is highly passionate about entrepreneurship, having founded two successful start-ups as an undergraduate. Haiping is also the recipient of several international business awards, and holds a B.Eng (Material Science & Engineering) from the National University of Singapore.